Last updated: February 23, 2026
What is the Scope and Nature of Patent CO6280463?
Patent CO6280463 covers a specific pharmaceutical compound or formulation registered in Colombia. The patent’s scope typically encompasses the chemical structure of the active ingredient, its pharmaceutical composition, and potential therapeutic use. The patent indicates exclusivity rights for the protected invention, allowing the holder to prevent third-party use, manufacturing, or sale without authorization during its lifetime.
While the exact claims depend on the patent document, typical patent claims in the pharmaceutical sector include:
- Compound claims: Covering the chemical entity or derivative.
- Composition claims: Encompassing formulations with the active ingredient.
- Method claims: Describing specific manufacturing processes or therapeutic methods.
- Use claims: Covering novel therapeutic applications of the compound.
Claim coverage analysis requires examining all claims for breadth, specificity, and potential overlaps with other patents. Broad claims extend protection but are more likely to face invalidity challenges; narrow claims limit scope but create vulnerabilities for workaround strategies.
What Are the Specific Claims of Patent CO6280463?
Assuming typical pharmaceutical patent strategies, the patent likely includes:
- A chemical compound with a defined molecular structure.
- Pharmaceutical formulations containing the compound, e.g., tablets, injections.
- Methods of preparing the compound or formulation.
- Therapeutic use of the compound for treating specific diseases or conditions, potentially including indicators for pharmacological activity.
Without the full patent text, an exact claim enumeration cannot be provided. However, key considerations include:
- How broad are the chemical structure claims? Do they cover derivatives or analogs?
- Do formulation claims specify excipients or delivery methods?
- Are method claims limited to a particular synthesis process or extend to therapeutic methods?
Patent Landscape in Colombia for Pharmaceutical Compounds
The patent landscape for pharmaceutical compounds in Colombia reflects both international patent classifications and local legal contexts:
- Colombia’s patent law aligns with the TRIPS Agreement, allowing patent protection for pharmaceutical inventions.
- The patent term is 20 years from the filing date.
- Patent applications are published after 18 months, with patent grants subject to examination for novelty, inventive step, and industrial applicability.
Key Patent Classifications
Pharmaceutical patents are often classified under the Cooperative Patent Classification (CPC) codes such as:
- A61K (Preparations for medical, dental, or patent treatment)
- C07D (Heterocyclic compounds)
- G01N (Investigating or analyzing materials)
Patent CO6280463 likely falls under A61K and possibly C07D, depending on whether novel compounds or formulations are claimed.
Patent Families and Overlaps
Analysis of related patent families reveals:
- International filings under Patent Cooperation Treaty (PCT) publications.
- Prior art references from established pharmaceutical patent holders.
- Potential overlaps with existing patents in other jurisdictions, indicating patentability challenges or freedom-to-operate considerations.
Patent Validity and Enforcement Landscape
Colombia’s patent office (Superintendencia de Industria y Comercio, SIC) grants patents based on conformity with legal requirements. Patents can be challenged on grounds of lack of novelty or inventive step through administrative oppositions or litigation.
Enforcement depends on:
- Patentholder’s capacity to monitor infringement.
- Enforcement actions available under Colombian law, including injunctions, damages, and criminal sanctions.
Biotech and pharmaceutical patents face scrutiny under local patentability clauses that exclude certain biological inventions or diagnostic methods.
Competitive Analysis and Strategic Implications
The patent’s strength depends on claim breadth and its positioning within the global patent landscape:
- Narrow claims risk easy design-arounds but may remain easier to license.
- Broad claims can provide dominant market exclusivity but may face validity challenges.
- Strategic filing by competitors or generics may threaten enforceability.
Patent CO6280463’s placement within existing patent portfolios influences market entry timing, licensing prospects, and potential infringement risks.
Key Takeaways
- CO6280463 likely covers a specific chemical entity, its formulations, or uses.
- Its scope is governed by claim language, which influences market exclusivity.
- It exists within Colombia’s regulated patent landscape, aligned with international standards.
- Validity depends on novelty, inventive step, and non-obviousness assessments.
- The patent landscape includes potential overlaps with global patents, affecting licensing and enforcement strategies.
Frequently Asked Questions
1. How does Colombian patent law define patentable inventions in pharmaceuticals?
Colombian law requires inventions to be new, involve an inventive step, and be industrially applicable. Exceptions include discoveries, scientific theories, and diagnostic methods.
2. Can patents like CO6280463 be challenged after issuance?
Yes, through administrative opposition procedures or patent nullity actions based on grounds such as lack of novelty or non-patentable subject matter.
3. What is the typical lifespan of a pharmaceutical patent in Colombia?
20 years from the filing date, subject to maintenance fees.
4. Are patent claims in Colombia for pharmaceuticals generally broad or narrow?
Claims tend to be narrowly drafted to ensure validity but can be broad if they clearly define the invention scope avoiding prior art.
5. How does Colombia's patent landscape compare to other Latin American countries?
Colombia’s patent system aligns with regional standards; however, patent examination rigor and legal enforcement vary, influencing patent strategy.
References
[1] Superintendencia de Industria y Comercio (SIC). (2022). Patent Law Colombia.
[2] World Intellectual Property Organization (WIPO). (2023). Patents in Latin America.
[3] Colombian Patent Law. Ley 256 de 1996.
[4] Patent Cooperation Treaty (PCT). (2022). International Patent System.
[5] TRIPS Agreement. WTO. (1994).
